Gravity Diagnostics Taps Industry Veteran to Steer National Growth Strategy

COVINGTON, KY – August 20, 2026 – In a move that signals a deliberate pivot from rapid, reactive growth to structured national expansion, Gravity Diagnostics has appointed Danielle Cimmento-Burkey to the newly created role of Director of Strategy & Leadership. The hire goes beyond a simple personnel announcement, reflecting a broader trend in the high-stakes diagnostics industry: the critical need for integrated commercial leadership to navigate an increasingly complex healthcare ecosystem.

For Gravity Diagnostics, a company that has experienced explosive growth over the past decade, the creation of this role is a strategic imperative. Cimmento-Burkey is tasked with shaping the company's commercial strategy, fostering sales leadership, and spearheading organizational growth initiatives. This appointment comes as the firm aims to leverage its foundation in compliance and innovation to deepen its footprint across all 50 states, strengthening its crucial partnerships with payors and government entities.

Architecting the Next Phase of Growth

Gravity Diagnostics is no stranger to expansion. Between 2019 and 2021, the company achieved a staggering 1,793% growth rate, expanding its physical footprint by 900% and its workforce more than tenfold. This trajectory, fueled in part by its significant role in COVID-19 testing, positioned the Covington-based lab as a major player. Now, the challenge shifts from managing explosive growth to sustaining and directing it. The creation of a directorship focused on strategy and leadership is a clear indicator of this maturation.

Cimmento-Burkey steps into an organization primed for this next phase. A $5 million investment secured in early 2025 was earmarked for enhancing facilities, expanding service offerings, and crucially, growing its sales and marketing functions. Her role is designed to be the nexus of these efforts, translating high-level strategic goals into actionable plans for a national commercial team. Her mandate involves not just expanding market share, but doing so in alignment with the company’s core values of “Care, Compliance, Confidence.”

“Danielle is recognized by her peers as one of the best in our industry at building and developing successful teams on a consistent basis,” said Tony Remington, Cofounder & CEO of Gravity Diagnostics, in the official announcement. “We are excited for her to join our organization as we continue to grow on a national level, focusing on compliance and working with our payor and government partners to provide superior care while reducing the economic impact of healthcare.”

A Proven Leader in a Complex Market

Cimmento-Burkey’s 13-year career is a case study in ascending from top-tier sales performance to strategic leadership. Her background demonstrates a deep understanding of the nuances of the laboratory diagnostics market. Most recently, as Area Director at HealthTrackRx, she was responsible for leading strategic sales initiatives and contributing to enterprise-wide transformation efforts. Before that, as a Regional Manager, she honed her passion for talent development, successfully recruiting and coaching numerous sales professionals to achieve the coveted President's Club recognition.

Her reputation as a team builder is backed by a history of personal excellence. During an eight-year tenure at Millennium Health, she rose to become the company’s top sales representative, exceeding her sales plan for seven consecutive years and building a top-ten company-wide ranking. This blend of individual achievement and a proven ability to elevate the performance of others is precisely what a company like Gravity Diagnostics needs to scale its culture of success. Her five President’s Club awards and a HealthTrackRx MVP Award are testaments to a career built on consistent, measurable results.

Navigating the New Diagnostics Landscape

The decision to establish this strategic role reflects powerful undercurrents shaping the entire diagnostics sector. The industry is rapidly moving beyond a transactional, fee-for-service model. Today, success hinges on demonstrating clinical and economic value to a diverse set of stakeholders, from individual physicians to large hospital systems, insurance providers, and government health agencies. This shift to value-based care requires a sophisticated commercial strategy that is deeply integrated with compliance and partnership development.

Gravity Diagnostics has already laid significant groundwork in this area. As a CAP-accredited and CLIA-certified laboratory, it has built a reputation for regulatory diligence. The company has also proven its ability to forge critical public and private partnerships, having worked with state health departments during the pandemic and secured in-network status with all major Managed Care Organizations (MCOs) in Kentucky. Cimmento-Burkey's role will be to build upon this foundation, ensuring that the sales organization can effectively communicate the value of the company’s comprehensive testing menu—which includes toxicology, pharmacogenetics, and infectious disease diagnostics—to these powerful gatekeepers.

Her leadership will be vital in navigating the reimbursement pressures and regulatory complexities that define the modern healthcare market. The goal is no longer just to sell a test, but to position diagnostics as an indispensable tool for improving patient outcomes and reducing the overall economic burden of healthcare, a vision explicitly stated by CEO Tony Remington. This requires a sales force that is as much a team of strategic consultants as it is a revenue engine, a transformation that Cimmento-Burkey is uniquely qualified to lead.